Merck Stock News

(RTTNews) - F-star Therapeutics Inc. (FSTX) said that Ares Trading S.A., an affiliate of Merck KGaA, Darmstadt, Germany has exercised a fourth licensing option to develop another bispecific program under the ongoing immuno-oncology collaboration. As per the terms of the deal, Merck KGaA will be responsible for all future development and

India has not added Merck''s pill to the list of treatments for Covid due to ''major safety concerns'', a top health official said today.

By Chris Wack F-star Therapeutics Inc. said Wednesday that Ares Trading SA, an affiliate of Merck KGaA, has exercised a fourth licensing option to develop

India-based Dr Reddy''s Laboratories Ltd (NYSE: RDY) will launch its generic version of Merck Co & Inc''s (NYSE: MRK) COVID-19

Drugmaker Dr Reddy''s Laboratories Ltd will launch its generic version of Merck''s antiviral COVID-19 pill, molnupiravir.

This article was originally published on TipRanks.com. The post FDA Grants Emergency Use Authorization to Mercks COVID-19 Treatment appeared first on Smarter Analyst .

Navalign LLC grew its holdings in Merck & Co., Inc. (NYSE:MRK) by 9.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 14,400 shares of the companys stock after buying an additional 1,287 shares during the quarter. Navalign LLCs holdings in Merck []

With not just one, but two COVID-19 antiviral pills in the works, the White House is getting ready to support both Pfizer and Merck.

I joked about LGs unusual TVs earlier this week, but I''ll take it back. Those were fine. Sensible, even. Thats because a Meiji University professor in Japan has unveiled a prototype screen called Taste the TV. The prototype sends electrical signals to 10 flavor canisters that spray flavors on a film overlay for those willing to lick. Creator Homei Miyashita thinks of the device as less of a taste-at-home device, and more as a tool for food professionals, like chefs and sommeliers. The prototype is, yes, a little icky, despite the hygienic film that can be treated between tastings. According to Reuters , Miyashita is already discussing spin-off applications for the spray tech, like applying pizza or chocolate flavors to a slice of toasted bread. Dont tell him about Nutella. Your daily TMA will be taking a few days off for the holidays, but we''ll be back next Wednesday. Have a great weekend! -Mat Smith Japan''s latest life-sized Gundam statue is almost complete The robot''s head has just been attached.

Japan has approved the COVID-19 pill developed by U.S. pharmaceutical company Merck & Co. for use beginning next week

Merck & Co. Inc.''s COVID-19 antiviral pill received the green light from an expert committee from the Japanese Ministry of Health, Labour and Welfare on Friday, according to the Japan Broadcas

WASHINGTON D.C.: The U.S. Food and Drug Administration (FDA) is expected to approve, within days, Pfizer''s and Merck''s groundbreaking pills to treat COVID-19, sources told Bloomberg News. Writing in the Guardian, Eric Topol, director of the Scripps Research Translational Institute, said the approval of Pfizer''s Paxlovid and Merck''s Molnupiravir would come at a time "when we absolutely need it," amidst the surge

Interferons suppress cell development, have antiviral effects, and regulate the immune system, among other things. Interferons are capable of rapidly replicating virus genomes and safeguarding cells against viral infections. These benefits are driving the market for interferons forward. Interferons'' antiviral

In the near future, expansion in the worldwide pharmaceutical industry is most expected to drive the global trypsin market. Furthermore, during the projection period, the minimal risk of viruses and other harmful agents in the trypsin solution is likely to